2L
RGNX icon

22NW LP’s Regenxbio RGNX Stock Holding History

22NW LP’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.13M Sell
492,759
-430,920
-47% -$4.53M 2.83% 10
2025
Q4 		$13.3M Hold
923,679
– – 5.6% 5
2025
Q3 		$8.91M Hold
923,679
– – 4.2% 7
2025
Q2 		$7.58M Buy
923,679
+255,000
+38% +$2.13M 4.78% 6
2025
Q1 		$4.78M Buy
+668,679
New +$4.97M 3.21% 10

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

22NW LP's RGNX Position: Q1 2026 in Review

22NW LP reduced its Regenxbio (RGNX) stake by 47% in Q1 2026, selling an estimated $4.53M and leaving 492,759 shares worth $4.13M. The position accounts for 2.83% of the portfolio, ranked #10.

22NW LP first reported a position in RGNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $13.3M in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • 22NW LP held 492,759 shares of Regenxbio worth $4.13M as of Q1 2026.
  • 22NW LP sold 430,920 Regenxbio shares in Q1 2026, an estimated $4.53M.
  • Regenxbio made up 2.83% of 22NW LP's portfolio in Q1 2026, its #10 holding.
  • 22NW LP first reported a position in Regenxbio in Q1 2025 and has held it in 5 quarters since.
  • 22NW LP's Regenxbio position peaked at $13.3M in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on 22NW LP's 13F filing for Q1 2026, filed 15 May 2026.